Jiangxi Yintao Pharmaceutical Co., Ltd.

The purpose of this study is to study the single-dose and multiple-dose pharmacokinetic studies of Ozagrel Hydrochloride Tablets provided by Tongliao Huabang Pharmaceutical Co., Ltd. in healthy volunteers. By establishing the methodology of Ozagrel and its metabolites in blood samples and detecting plasma samples, the corresponding pharmacokinetic parameters are obtained to understand the dynamic changes of Ozagrel Hydrochloride Tablets in the human body and the accumulation in the body after multiple continuous administrations, so as to provide a basis for rational clinical drug use.

Based on preclinical studies, this study used "change in throat pain VAS score compared with baseline on the 3rd day" as the main efficacy indicator, and adopted a randomized, double-blind, placebo-controlled, multicenter clinical verification trial design to evaluate the efficacy and safety of Xingxiang Tuerfeng Capsule in the treatment of acute pharyngitis (lung and stomach heat syndrome), to supplement the results of previous clinical studies, and to provide a basis for adding the indication of "treatment of acute pharyngitis".

To preliminarily evaluate the efficacy and safety of Yanli Capsule in the treatment of functional erectile dysfunction (kidney yang deficiency syndrome).